Rubius Therapeutics OverviewRubius Therapeutics Operating Income
Operating Income for RUBY.
Quarterly Operating Income
$-127000.00
↓ 99.76% YoY
As of Dec 31, 2022
Annual Operating Income (TTM)
$-155477000.00
↓ 20.11% YoY
Trailing 12 months ending Dec 31, 2022